Board of Pharmacy Perspective on Enforcing USP Standards
ARL Bio Pharma
Board of Pharmacy Perspective on Enforcing USP Standards
34:24
Peering Beyond the Chapter Elevating Sterile Compounding Practices
ARL Bio Pharma
Peering Beyond the Chapter Elevating Sterile Compounding Practices
1:02:38
Sterility and Alternative Sterility Testing
ARL Bio Pharma
Sterility and Alternative Sterility Testing
57:48
USP 795 Updates and Cultivating a Culture of Quality within Your Team
ARL Bio Pharma
USP 795 Updates and Cultivating a Culture of Quality within Your Team
44:11
Today’s USP 797: A Functional Approach to Quality Sterile Compounding
ARL Bio Pharma
Today’s USP 797: A Functional Approach to Quality Sterile Compounding
1:02:18
Beyond The Survey Top Findings and How to Implement Change in Your Pharmacy
ARL Bio Pharma
Beyond The Survey Top Findings and How to Implement Change in Your Pharmacy
54:01
ARL Celebrates 25 Years - Microbiology
ARL Bio Pharma
ARL Celebrates 25 Years - Microbiology
0:35
Rapid Sterility Testing: An Alternative Microbiological Method
ARL Bio Pharma
Rapid Sterility Testing: An Alternative Microbiological Method
59:41
USP 51 Antimicrobial Effectiveness Testing & USP 71 Sterility Testing When, Why, and How
ARL Bio Pharma
USP 51 Antimicrobial Effectiveness Testing & USP 71 Sterility Testing When, Why, and How
58:30
Understanding USP 797 Microbiology Testing Requirements
ARL Bio Pharma
Understanding USP 797 Microbiology Testing Requirements
1:01:11
Compounding Lab Design and Engineering Considerations per USP 800 Guidelines
ARL Bio Pharma
Compounding Lab Design and Engineering Considerations per USP 800 Guidelines
1:03:20
The Itch You Cannot Scratch: Veterinary Dermatology
ARL Bio Pharma
The Itch You Cannot Scratch: Veterinary Dermatology
1:01:36
Stability Testing Science and Compliance
ARL Bio Pharma
Stability Testing Science and Compliance
1:03:53
QCS Session #9 - Panel Discussion
ARL Bio Pharma
QCS Session #9 - Panel Discussion
52:54
QCS Session #2 - Pharmacist/Provider/Patient Triad: A Multidisciplinary Approach to Patient Care
ARL Bio Pharma
QCS Session #2 - Pharmacist/Provider/Patient Triad: A Multidisciplinary Approach to Patient Care
59:51
QCS Session #1 -NABP Implementation of the FDA Compounding MOU
ARL Bio Pharma
QCS Session #1 -NABP Implementation of the FDA Compounding MOU
43:21
QCS Session #8 - Sterility Assurance using Sterile Compounding Automation and Technology
ARL Bio Pharma
QCS Session #8 - Sterility Assurance using Sterile Compounding Automation and Technology
42:58
QCS Session #7 - API or Approved Product: Where do we start with veterinary compounds?
ARL Bio Pharma
QCS Session #7 - API or Approved Product: Where do we start with veterinary compounds?
53:21
QCS Session #6 - Cleanroom Certification - Digging Deeper
ARL Bio Pharma
QCS Session #6 - Cleanroom Certification - Digging Deeper
57:19
QCS Session #4 - Regulatory and Quality Considerations in the Selection of API
ARL Bio Pharma
QCS Session #4 - Regulatory and Quality Considerations in the Selection of API
43:55
QCS Session #3 - Quality Compounding and Clinical Pharmaceutics
ARL Bio Pharma
QCS Session #3 - Quality Compounding and Clinical Pharmaceutics
1:10:24
QCS Session #5 - Root Cause of Stability Failures
ARL Bio Pharma
QCS Session #5 - Root Cause of Stability Failures
45:50
How Can Attendees Engage in QCS
ARL Bio Pharma
How Can Attendees Engage in QCS
1:00
What are Important Topics in the Industry Today?
ARL Bio Pharma
What are Important Topics in the Industry Today?
2:13
QCS: Regulatory and Quality Considerations in the Selection of Active Pharmaceutical Ingredients
ARL Bio Pharma
QCS: Regulatory and Quality Considerations in the Selection of Active Pharmaceutical Ingredients
3:04
Happy National Pharmacy Week
ARL Bio Pharma
Happy National Pharmacy Week
1:58
Quality Compounding Summit: What Session Are You Most Excited About?
ARL Bio Pharma
Quality Compounding Summit: What Session Are You Most Excited About?
1:53
QCS Session 2: Pharmacist/Provider/Patient Triad: A Multidisciplinary Approach to Patient Care
ARL Bio Pharma
QCS Session 2: Pharmacist/Provider/Patient Triad: A Multidisciplinary Approach to Patient Care
1:36
Quality Compounding Summit
ARL Bio Pharma
Quality Compounding Summit
2:09
Raw Materials Revealed
ARL Bio Pharma
Raw Materials Revealed
54:02
A Pharmacist's Prescription for Bringing in New Customers
ARL Bio Pharma
A Pharmacist's Prescription for Bringing in New Customers
37:11
An Inside Look at ARL's Rapid Sterility Test
ARL Bio Pharma
An Inside Look at ARL's Rapid Sterility Test
3:43
Insurance Considerations for Pharmacists and Professional Liability in Compounding
ARL Bio Pharma
Insurance Considerations for Pharmacists and Professional Liability in Compounding
1:02:12
ARL Rapid Sterility Testing
ARL Bio Pharma
ARL Rapid Sterility Testing
1:10
SpecRx: ARL Rapid Sterility Testing - 20Ways Winter Hospital 2020
ARL Bio Pharma
SpecRx: ARL Rapid Sterility Testing - 20Ways Winter Hospital 2020
1:10
COVID-19 Testing and Therapeutics
ARL Bio Pharma
COVID-19 Testing and Therapeutics
55:25
Minor Chapters Major Impacts: What USP 51, 61 and 1207 Mean for Your Practice
ARL Bio Pharma
Minor Chapters Major Impacts: What USP 51, 61 and 1207 Mean for Your Practice
58:54
More Than Selling Compounds! Webinar
ARL Bio Pharma
More Than Selling Compounds! Webinar
1:01:34
First Do No Harm: Considerations of Safety and Efficacy Factors for Delivery of Drugs to the Eye
ARL Bio Pharma
First Do No Harm: Considerations of Safety and Efficacy Factors for Delivery of Drugs to the Eye
4:55
Insurance Considerations for Pharmacists and Professional Liability in Compounding
ARL Bio Pharma
Insurance Considerations for Pharmacists and Professional Liability in Compounding
1:10
Future Technology and Automation in Pharmaceutical Compounding
ARL Bio Pharma
Future Technology and Automation in Pharmaceutical Compounding
2:46
Innovative Approaches to Implementing USP Compounding Standards
ARL Bio Pharma
Innovative Approaches to Implementing USP Compounding Standards
1:33
Minor Chapters, Major Impacts: What USP 51, 61 and 1207 Mean for Your Practice
ARL Bio Pharma
Minor Chapters, Major Impacts: What USP 51, 61 and 1207 Mean for Your Practice
1:36
Stability Testing: Science and Compliance
ARL Bio Pharma
Stability Testing: Science and Compliance
43:09
Rapid Sterility Testing Strategies for Compounded Sterile Preparations
ARL Bio Pharma
Rapid Sterility Testing Strategies for Compounded Sterile Preparations
56:33
Discover New Business Opportunities for Your Pharmacy
ARL Bio Pharma
Discover New Business Opportunities for Your Pharmacy
59:48
Rapid Sterility Testing
ARL Bio Pharma
Rapid Sterility Testing
45:26
USP 800 Update – What is the current status and how do pharmacists proceed?
ARL Bio Pharma
USP 800 Update – What is the current status and how do pharmacists proceed?
58:09
Beyond Use Date Strategies for Compounded Sterile Preparations
ARL Bio Pharma
Beyond Use Date Strategies for Compounded Sterile Preparations
1:00:46
USP General Chapters and Compounded Monograph Chapters: Best Practices and Regulatory Guidance
ARL Bio Pharma
USP General Chapters and Compounded Monograph Chapters: Best Practices and Regulatory Guidance
59:31
ARL Bio Pharma's Cleanroom
ARL Bio Pharma
ARL Bio Pharma's Cleanroom
2:40
Medical Marijuana (THC and CBD) Pharmacology, Regulation, and Pharmacy Considerations
ARL Bio Pharma
Medical Marijuana (THC and CBD) Pharmacology, Regulation, and Pharmacy Considerations
52:05
The Practical Use of the USP as a Primary Reference Resource in Compounded Formulations
ARL Bio Pharma
The Practical Use of the USP as a Primary Reference Resource in Compounded Formulations
50:39
Stability Studies: The Architecture Behind Establishing a Beyond Use Date
ARL Bio Pharma
Stability Studies: The Architecture Behind Establishing a Beyond Use Date
1:00:23
Stability Indicating Methods
ARL Bio Pharma
Stability Indicating Methods
59:07
Microbiology Testing: USP requirements for Sterile and Nonsterile Preparations
ARL Bio Pharma
Microbiology Testing: USP requirements for Sterile and Nonsterile Preparations
56:39
Extending Beyond Use Dates for Compounded Preparations
ARL Bio Pharma
Extending Beyond Use Dates for Compounded Preparations
59:15
An Inside Look at USP 71
ARL Bio Pharma
An Inside Look at USP 71
51:39
Extending Beyond Use Dating and Release Testing
ARL Bio Pharma
Extending Beyond Use Dating and Release Testing
59:27
Quality Compounding Summit www.qcsummitrx.org
ARL Bio Pharma
Quality Compounding Summit www.qcsummitrx.org
0:21